Toremifene and tamoxifen in advanced breast cancer - a double-blind cross-over trial

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

1977 • 8,468 citations

WHO Handbook for Reporting Results of Cancer Treatment

1982 • 2,214 citations

A new triphenylethylene compound, Fc-1157a

1986 • 149 citations

A new triphenylethylene compound, Fc-1157a

1986 • 137 citations

Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer. Phase II study

1988 • 100 citations

Evaluation of tamoxifen dose in advanced breast cancer: a progress report.

1976 • 97 citations

Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.

1988 • 74 citations

Immunohistochemical demonstration of estrogen receptors (ER) in formalin-fixed, paraffin-embedded human breast cancer tissue by use of a monoclonal antibody to ER.

1988 • 59 citations

Endocrine Therapy of Advanced Breast Cancer

1988 • 54 citations

High dose toremifene in advanced breast cancer resistant to or relapsed during tamoxifen treatment

1994 • 43 citations

Charts for the early stopping of pilot studies.

1984 • 39 citations

Phase I study of toremifene in patients with advanced cancer.

1991 • 34 citations

High dose toremifene (240 mg daily) is effective as first line hormonal treatment in advanced breast cancer an ongoing phase II multicenter Finnish-Latvian cooperative study

1990 • 25 citations

Tamoxifen-induced remission in breast cancer by escalating the dose to 40 mg daily after progression on 20 mg daily: A case report and review of the literature

1981 • 24 citations

Phase II study of high dose toremifene in advanced breast cancer progressing during tamoxifene treatment.

1991 • 21 citations

Toremifene, a new antiestrogenic compound in the treatment of metastatic mammary cancer. A phase II study

1990 • 20 citations

Phase II clinical study of toremifene in patients with metastatic breast cancer. Preliminary communication

1990 • 20 citations

Phase III studies of toremifene in metastatic breast cancer

1990 • 18 citations

Phase II clinical study of high-dose toremifene in patients with advanced breast cancer

1990 • 10 citations

Impact of standardization of estrogen and progesterone receptor assays of breast cancer biopsies in Denmark

1988 • 10 citations